Fingolimod (Gilenya) and lymphopenia risk
German and Swedish studies suggest that underweight women and people with a low lymphocyte count when they start treatment with fingolimod (Gilenya) have a higher risk of lymphopenia (a deficiency in white blood cells) and will need careful monitoring.
MedPage Today
Fingolimod (Gilenya) - A to Z of MS
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news